Revance Therapeutics, Inc. (RVNC) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to loss of $0.74 per share a year ago. These ...
Source LinkRevance Therapeutics, Inc. (RVNC) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to loss of $0.74 per share a year ago. These ...
Source Link
Comments